SMN associated proteins and compounds for SMA therapy
SMN associated proteins and compounds for SMA therapy
批准号:
6753526
负责人:
JIANHUA ZHOU
金额:
$27.24万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2006-05-31
关键词:
DNA binding proteinRNA splicingbeta lactamasebiological signal transductiondegenerative motor system diseasedisease /disorder modelgene deletion mutationgene expressiongenetically modified animalsgreen fluorescent proteinsimmunoprecipitationlaboratory mouselaboratory rabbitmessenger RNAmicroarray technologymotor neuronsneuropharmacologypathologic processphosphatase inhibitorprogressive spinal muscular atrophyprotein structure functionsmall nuclear ribonucleoproteinstelomeretissue /cell cultureyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The autosomal recessive spinal muscular atrophy (SMA) is one of the most common
genetic causes of infant death. In SMA, there is anterior horn cell death and
muscle weakness. Deletions or mutations in the survival motor neuron gene, SMN,
are responsible for the disease. There are two SMN genes. However, only
telomeric copy (SMNt or SMNI) causes disease. Due to a single nucleotide
difference, T in the second gene SMN2 from C in SMNI, the majority of SMN2 mRNA
or protein skips exon7, resulting in an unstable SMNA7 protein and reduction of
its oligomerization ability. Therefore, the presence of the SMN2 gene in SMA
patients can not compensate for the loss of the SMNI gene. To understand the
pathogenesis of SMA, the first goal of this proposal is to use the yeast
two-hybrid screens to identify SMN interacting proteins, particularly those
from motor neurons. The interactions will be further characterized by other
complementary methods including mammalian two hybrid assays, in vitro binding
assays and in vivo co-immunoprecipitation assays. The biological significance
of interactions between SMN and its interactors will be investigated in cell
lines, and as long-term goals, in animal models. The second goal of this
proposal is to develop cell-based systems for therapeutic studies of SMA based
on the hypothesis that increasing of total or full-length SMN protein from SMN2
would reduce the severity of SMA. Stable cell lines and transgenic mice
expressing exon 7 splicing cassettes with reporters such as GFP, luciferase or
P-lactamase will be established. Both high and low throughput screening (HTS,
LTS) will be used to identify small molecules to promote inclusion of exon 7 in
SMN2 mRNA and protein. These compounds will be tested in SMA mouse models.
Signal pathways and other mechanisms that regulate RNA splicing of SMN genes
will be investigated.
1
ZNS1 SRB R(01) 3 1 R01 NS41665-01
DECEMBER 13-14, 2000 ZHOU, DR. JIANHUA
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of Complement Pathways with VCP As A Treatment For Alzheimer's Disease
-
批准号:10602757
-
项目类别:
-
资助金额:$49.72万
-
财政年份:2023
-
负责人:JIANHUA ZHOU
-
依托单位:
Cell Based Assays for Compounds That Regulate Tau Exon 10 Splicing
-
批准号:7424262
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2007
-
负责人:JIANHUA ZHOU
-
依托单位:
Targeting Bcl-x splicing for cancer treatment
-
批准号:7282095
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2006
-
负责人:JIANHUA ZHOU
-
依托单位:
Targeting Bcl-x splicing for cancer treatment
-
批准号:7151742
-
项目类别:
-
资助金额:$8.13万
-
财政年份:2006
-
负责人:JIANHUA ZHOU
-
依托单位:
Compounds regulating BACE 1 splicing and activity
-
批准号:6835625
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2003
-
负责人:JIANHUA ZHOU
-
依托单位:
Compounds regulating BACE 1 splicing and activity
-
批准号:6727375
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2003
-
负责人:JIANHUA ZHOU
-
依托单位:
A cell base system for compounds regulating tau splicing
-
批准号:6689539
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2002
-
负责人:JIANHUA ZHOU
-
依托单位:
A cell base system for compounds regulating tau splicing
-
批准号:6581033
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2002
-
负责人:JIANHUA ZHOU
-
依托单位:
SMN associated proteins and compounds for SMA therapy
-
批准号:6335861
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2001
-
负责人:JIANHUA ZHOU
-
依托单位:
SMN associated proteins and compounds for SMA therapy
-
批准号:6900972
-
项目类别:
-
资助金额:$27.24万
-
财政年份:2001
-
负责人:JIANHUA ZHOU
-
依托单位:
SMN associated proteins and compounds for SMA therapy
-
批准号:6540457
-
项目类别:
-
资助金额:$23.26万
-
财政年份:2001
-
负责人:JIANHUA ZHOU
-
依托单位:
SMN associated proteins and compounds for SMA therapy
-
批准号:6639776
-
项目类别:
-
资助金额:$23.26万
-
财政年份:2001
-
负责人:JIANHUA ZHOU
-
依托单位:
SMN associated proteins and compounds for SMA therapy
-
批准号:6573820
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2001
-
负责人:JIANHUA ZHOU
-
依托单位:
海外基金